Company Inter Pharma Company Srl with Fiscal Code 17787251
recorded a turnover of 2024 of
255.800,
with a net profit of
20.965
and having an average number of employees of
1.
The company operates in the field of Comerţ cu ridicata al produselor cosmetice şi de parfumerie having the NACE code 4645.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Inter Pharma Company Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
60.197
80.125
85.342
93.035
134.311
114.811
133.255
186.516
229.263
255.800
Total Income - EUR
60.141
80.258
88.188
93.838
135.235
115.054
133.840
187.792
229.273
258.928
Total Expenses - EUR
58.278
83.366
85.580
92.304
130.661
111.338
127.666
185.203
214.159
232.333
Gross Profit/Loss - EUR
1.862
-3.108
2.608
1.534
4.574
3.716
6.174
2.589
15.114
26.594
Net Profit/Loss - EUR
66
-4.706
1.425
601
3.233
2.655
4.998
1.008
13.093
20.965
Employees
1
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 12.2%, from 229.263 euro in the year 2023, to 255.800 euro in 2024.
The Net Profit increased by 7.945 euro, from 13.093 euro in 2023, to 20.965 in the last year.
Check the financial reports for the company - Inter Pharma Company Srl
Financial Rating - INTER PHARMA COMPANY SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Inter Pharma Company Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Inter Pharma Company Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Inter Pharma Company Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Inter Pharma Company Srl - CUI 17787251
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
632
0
0
22.818
40.780
31.714
22.903
14.840
10.075
2.451
Current Assets
58.575
57.144
40.310
52.222
45.762
42.054
49.456
51.377
71.924
82.570
Inventories
22.244
24.987
15.838
28.406
26.439
22.450
24.598
20.065
37.967
29.994
Receivables
35.928
26.529
23.428
16.870
16.926
17.925
16.966
28.508
21.245
22.532
Cash
404
5.628
1.044
6.946
2.397
1.679
7.893
2.805
12.712
30.044
Shareholders Funds
-1.508
-6.199
-4.670
-3.982
-672
1.996
6.949
7.979
21.048
41.894
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
60.718
63.359
45.001
79.503
87.843
72.187
65.973
58.962
61.217
43.290
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4645 - 4645"
CAEN Financial Year
4645
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
82.570 euro in 2024 which includes Inventories of
29.994 euro, Receivables of
22.532 euro and cash availability of
30.044 euro.
The company's Equity was valued at
41.894 euro, while total Liabilities amounted to
43.290 euro.
Equity increased by 20.964 euro, from 21.048 euro in 2023, to 41.894 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Inter Pharma Company Srl